The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data

Article Public, Environmental & Occupational Health

Predictors of the intention to receive a SARS-CoV-2 vaccine

Brian P. Meier et al.

Summary: Understanding the predictors of vaccine hesitancy is crucial for current and future pandemics. Encouraging vaccination requires multiple strategies, and the highlighted predictors, both here and elsewhere, are likely to be useful targets.

JOURNAL OF PUBLIC HEALTH (2022)

Add to Collection

Letter Rheumatology

COVID-19 vaccination in immunocompromised patients

Bhavin Sonani et al.

CLINICAL RHEUMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Immunosuppression as a risk factor for COVID-19: a meta-analysis

Daniel Tassone et al.

Summary: This study found that immunosuppressed patients were not significantly at increased risk of COVID-19 infection compared to the general population.

INTERNAL MEDICINE JOURNAL (2021)

Add to Collection

Letter Medicine, General & Internal

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Sharon Amit et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications

Elise Paul et al.

Summary: This study identified predictors of negative attitudes towards vaccines and unwillingness to receive a COVID-19 vaccine among UK adults, with low-income groups, those who did not receive a flu vaccine last year, poor adherence to COVID-19 guidelines, female gender, and living with children being the most significant predictors of vaccine refusal. High levels of mistrust in vaccine benefit and concerns about future side effects were the most important determinants of vaccine uncertainty and unwillingness to vaccinate against COVID-19.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Multidisciplinary Sciences